Interactive map of lung cancer screening
The interactive map of lung cancer screening is a comprehensive resource that showcases low-dose computed tomography (LDCT) screening programmes around the world.
View the map
Increasing the earlier detection of lung cancer: a toolbox for change
This report presents practical and evidence-based tools to support the development and implementation of an early detection strategy for lung cancer.
Find out more
Care pathways for lung cancer: building a foundation for optimal care
This report explores the essential role that care pathways play in delivering best-practice lung cancer care. Currently, only a small number of countries and regions have established formal care pathways for lung cancer.
Find out more
Lung cancer screening implementation toolkit
The Lung Cancer Policy Network has developed an implementation framework to support those involved in the planning of lung cancer screening programmes around the world.
Implementation toolkitMaking lung cancer a global policy priority
Our vision is a world where long-term survival for everyone facing lung cancer is the norm. We work to make lung cancer a policy priority across the globe and equip people with evidence-based policy solutions to improve survival through screening, earlier detection and optimal care.
Find out moreWhat we do
The Lung Cancer Policy Network is a global, multidisciplinary alliance working to improve survival outcomes by strengthening lung cancer policy worldwide. We bring together experts across countries and sectors to generate evidence, share best practice and effect policy change across the full continuum of care.
Why lung cancer?
Many of us will be affected by lung cancer. It is the leading cause of cancer-related death globally, accounting for one in five deaths.1 Most people are diagnosed at a late stage, when treatment options are limited and outcomes are poorest – meaning more people die from the disease than they ought to.2 3
Lung cancer is also a disease that has strong links with inequality. It disproportionately affects people and communities of low socioeconomic position in every aspect: from risk of lung cancer through to access to the services and care they need.4 This means that people’s outcomes can be impacted by where they live, or who they are.
Tackling lung cancer involves some of the toughest challenges we currently face as a global community: inequity, climate change, air pollution, funding. And improving survival requires coordinated action across screening, earlier detection and diagnosis, and optimal care.
Our areas of work
Our programmes are designed to support policymakers, advocates and health system leaders to implement effective solutions.
Screening
We provide tools and insights to support implementing and optimising low-dose computed tomography (LDCT) screening programmes for those at highest risk.
Earlier detection and diagnosis
We support comprehensive approaches to detecting lung cancer earlier, including improving symptom awareness, referral pathways and diagnostic systems.
Optimal care
We promote effective care pathways and system approaches to ensure timely diagnosis, treatment and improved outcomes.
References
Bray F, Laversanne M, Sung H, et al. 2024. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3): 229-63
Gildea TR, Stacey DB, Kyle HD, et al. 2017. A retrospective analysis of delays in the diagnosis of lung cancer and associated costs. Clinecon Outcomes Res 9(null): 261-69
Zhang J, Ijzerman MJ, Oberoi J, et al. 2022. Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomes. Lung Cancer 166: 27-39
Redondo-Sánchez D, Petrova D, Rodríguez-Barranco M, et al. 2022. Socio-Economic Inequalities in Lung Cancer Outcomes: An Overview of Systematic Reviews. Cancers 14(2): 398